Sarkari Yojana
Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India
About Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India
The Department of Pharmaceuticals, Ministry Of Chemicals And Fertilizers, Government of India, runs the “Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India” to grow domestic manufacturing of identified KSMs, DIs, and APIs by offering manufacturers financial incentives on incremental sales. It focuses on 41 identified products spanning critical APIs, aiming to cut import dependence, and applies only to greenfield projects, encouraging large-scale investment in the pharmaceutical sector.
- Tenure of the Scheme: The scheme runs from FY 2020-21 to FY 2029-30.
- Base Year: Financial Year 2019-20.
- Financial Outlay: The scheme carries a total financial outlay of Rs. 6,940 crore.
- Basis of Computation: Threshold investment and sales of manufactured products get assessed from details furnished to the Departments/Ministries/Agencies, alongside Statutory Auditor certificates.
Project Management Agency: The Industrial Finance Corporation of India (IFCI) serves as the Nodal Agency and Project Management Agency (PMA) implementing the scheme.
Scheme Overview
Central Government
Ministry Of Chemicals And Fertilizers
Business Entity
21 Jul 2026
Scheme Details
Eligibility Requirements
To qualify for Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India, applicants must satisfy the following conditions:
Applicability: The scheme applies only to greenfield projects.
Eligibility
Support under the scheme goes only to manufacturers…
Support under the scheme goes only to manufacturers of critical KSMs/DIs and APIs registered in India.
Eligibility depends on threshold investment in greenfield projects,…
Eligibility depends on threshold investment in greenfield projects, as set out in the table below.
Eligibility under this scheme does not affect, and…
Eligibility under this scheme does not affect, and is not affected by, eligibility under any other scheme. Eligibility Threshold Criteria: S. NoSegmentThreshold Investment1.Fermentation based 04 KSMs /Drug Intermediates₹400,00,00,000/-2.Fermentation based 10 niche KSMs / Drug Intermediates / APIs₹50,00,00,000/-3.Key Chemical Synthesis based 04 KSMs /Drug Intermediates₹50,00,00,000/-4.Other 23 Chemical Synthesis based KSMs / Drug Intermediates / APIs₹20,00,00,000/-
Benefits Provided
Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India provides the following benefits to eligible applicants:
Financial Incentive on Sales:
Sales of 41 identified products are eligible for…
Sales of 41 identified products are eligible for incentive over a 6-year period. Target Segments:
The 41 products fall under four Target Segments,…
The 41 products fall under four Target Segments, listed in Annexure B. For Fermentation-Based Products:
A 20% incentive applies from FY 2023-24 to…
A 20% incentive applies from FY 2023-24 to FY 2026-27.
This drops to 15% in FY 2027-28
This drops to 15% in FY 2027-28.
And further to 5% in FY 2028-29
And further to 5% in FY 2028-29. For Chemical Synthesis-Based Products:
A 10% incentive applies from FY 2022-23 to…
A 10% incentive applies from FY 2022-23 to FY 2027-28. Coverage of Products:
The incentive covers 41 products spanning 53 critical…
The incentive covers 41 products spanning 53 critical APIs.
Documents Required
Applicants should keep the following documents ready before starting the application:
Constitution of Business:
A copy of the memorandum and articles of association or equivalent registration document, Partnership Deed, and any equivalent document, along with the Shareholding pattern/share of partners, as applicable.
Business Details
Business Details:
Self-certified copies of the applicant's PAN and…
Self-certified copies of the applicant's PAN and GST Certificate.
Self-certified copies of a brief profile of the Chairman, CEO, CXOs, Promoter, and Key Managerial Persons, along with their PAN / DIN.
Self-certified copies of Annual Reports, including Annual Financial Reports with schedules and the audited, complete Balance Sheet, for the last 3 years, with the most recent reports provided.
Credit History:
A certificate from the Company Secretary / Board of Directors/ Managing Partner or Owner of the Proprietorship Firm.
Key Personnel Details:
Contact details of three senior employees of the applicant, including Name, Designation, Address, phone, and email.
Net Worth of the Applicant and/ or group…
Net Worth of the Applicant and/ or group companies as on the date of application: A certificate from the Statutory Auditor or an Independent Chartered Accountant, as applicable.
Self-certified Financial Details (last 3 years)
Self-certified Financial Details (last 3 years).
Research and Development facility details
Research and Development facility details.
Project Details
Project Details.
Domestic Value Addition details
Domestic Value Addition details.
A Project Report for the eligible product
A Project Report for the eligible product.
Application Fee Details
Application Fee Details.
Note
Note: Detailed information regarding the documentation for the application process is available in the Guidelines ( Annexure 1 ).
2026-07-21
How to Apply
Online Application
Applicants can apply for Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India through the online application process outlined below.
Application Process
Only the online mode is available to eligible applicants. The application link is:
https://plibulkdrugs.ifciltd.com/login
Contact:
Click here
.
Application Fee under the Scheme:
S. No.
Name of the Eligible Product
Application Fee
1.
Penicillin G, 7-ACA, Erythromycin Thiocynate (TIOC), Clavulanic Acid
₹1,00,000/-
2.
All other eligible products
₹50,000/-
The Application Fee must be paid electronically via NEFT/RTGS to the bank account detailed below:
Bank Account Name : IFCI – PLI – Bulk Drugs
Account Number : 3859475896
Name of the Bank : Central Bank of India
IFSC Code : CBIN0281410
Branch Code : 1410
Branch Name : Nehru Place
Bank Address : Central Bank of India, 59, Shakuntala Building, Nehru Place, New Delhi - 110019
Official Application & Website
Verify the latest eligibility, dates and instructions before applying.